Therefore, we started to examine the crosstalk among AMPK, Nrf2, and NFκB in the alleviation of hepatic oxidative and inflammatory injury in high-fat-induced NAFLD. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatotic liver disease.